Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer

BACKGROUND: Appropriate assessment is essential for the management of chemotherapy-induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated, which is high on the list of causes of distress for cancer patients. However, objective assessment by medical staff makes it e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, K., Fujimoto, K., Mochizuki, R., Ishida, K., Lee, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734590/
https://www.ncbi.nlm.nih.gov/pubmed/31506070
http://dx.doi.org/10.1186/s12885-019-6113-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734590/
https://www.ncbi.nlm.nih.gov/pubmed/31506070
http://dx.doi.org/10.1186/s12885-019-6113-3

Ejemplares similares